Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Viral Meningitis

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

Bacterial Meningitis II: Pathophysiology

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...

Cytomegalovirus Disease

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

Arboviral Encephalitis

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community acquired bacterial meningitis in Cuba: a follow up of a decade.

BMC infectious diseases·2010

Same author

Safety and preliminary immunogenicity of MenC/P64k, a meningococcal serogroup C conjugate vaccine with a new recombinant carrier.

FEMS immunology and medical microbiology·2006

Same author

Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system.

BMC infectious diseases·2005

See all related articles

Search research articles

Related Experiment Video

Updated: May 24, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Meningococcal disease serogroup C.

Félix O Dickinson¹, Antonio E Pérez, Iván E Cuevas

¹Department of Epidemiology, "Pedro Kourí" Institute, Havana, Cuba.

Risk Management and Healthcare Policy

|March 20, 2012

Summary

Meningococcal disease serogroup C (MDC) poses a significant global health risk. Vaccination, particularly with conjugate vaccines, and prompt antibiotic treatment are key strategies for prevention and control.

Keywords:

disease management epidemiology public health significance vaccination strategies

More Related Videos

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Related Experiment Videos

Last Updated: May 24, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

Published on: May 7, 2020

Area of Science:

Public Health
Infectious Diseases
Vaccinology

Background:

Meningococcal disease serogroup C (MDC) remains a significant global health threat, causing high morbidity, mortality, and neurological sequelae.
Despite advances in treatment, individual case fatality rates approach 10%, and population-level control is challenging.
Prevention strategies include health education, chemoprophylaxis, and vaccination.

Purpose of the Study:

To review the current strategies for the prevention and control of meningococcal disease serogroup C.
To highlight the efficacy and benefits of meningococcal C conjugate vaccines.
To discuss the role of antibiotics and adjunctive therapies in managing MDC.

Main Methods:

Review of existing literature on meningococcal disease serogroup C epidemiology, treatment, and prevention.
Analysis of the effectiveness of polysaccharide and conjugate vaccines.
Discussion of antibiotic choices and the controversial role of steroids.

Main Results:

Meningococcal C conjugate vaccines are safe, well-tolerated, and effective, especially in infants, inducing immunogenicity, immunologic memory, and herd immunity.
Antibiotics like penicillin, ampicillin, chloramphenicol, and third-generation cephalosporins are crucial for empirical treatment.
Steroid use as adjunctive therapy remains debated.

Conclusions:

A combined approach of vaccination, prompt antibiotic therapy, and tailored public health policies is essential for MDC prevention and control.
Conjugate vaccines offer significant advantages over plain vaccines, including improved immunogenicity in infants and reduced carriage.
Countries should adapt strategies based on local disease burden and resistance patterns.